Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Investigating the effects of early pain and sucrose exposure on brain development using a newborn mouse model
EF 2025-26
Résumé
Each year, over 13 million babies are born prematurely worldwide. In developed countries, roughly two-thirds of these infants are admitted to the neonatal intensive care unit (NICU), where they undergo countless medical procedures to monitor and support them until they have reached full-term or are ready to go home. To reduce some of the stress and pain that these infants experience during this crucial developmental period, a solution of sugar and water (sucrose) is given to them, prior to undergoing certain painful procedures. Sucrose is known to have a calming effect on the nervous system; however, studies suggest that repeated exposure to sucrose in combination with pain may have negative effects on the developing brain. For example, in young mice, early and repetitive exposure to pain and/or sucrose negatively impacted several brain structures and long-term memory.
Through this study, we hope to better understand the mechanisms by which early pain in combination with sucrose treatment affects brain development in preterm infants. We specifically want to understand if inflammation and specific growth factors play key roles. We have established a mouse model that closely mimics the procedures that preterm infants experience in the NICU. We will assess if mice exposed to early pain and/or sucrose have altered levels of inflammatory markers and growth factors in the blood and brain. By assessing the molecular markers that may play a role in impacting the brain development of infants, we hope to develop a better treatment that protects the brain during this critical stage of development. This will ultimately allow these infants to live healthier and more comfortable lives.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573034
Name
Schraeder Emily
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the effects of early pain and sucrose exposure on brain development using a newborn mouse model
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cytokines; Inflammation; Insulin-Like Growth Factor; Neurodevelopment; Pain; Preterm; Sucrose
Abstract
Each year, over 13 million babies are born prematurely worldwide. In developed countries, roughly two-thirds of these infants are admitted to the neonatal intensive care unit (NICU), where they undergo countless medical procedures to monitor and support them until they have reached full-term or are ready to go home. To reduce some of the stress and pain that these infants experience during this crucial developmental period, a solution of sugar and water (sucrose) is given to them, prior to undergoing certain painful procedures. Sucrose is known to have a calming effect on the nervous system; however, studies suggest that repeated exposure to sucrose in combination with pain may have negative effects on the developing brain. For example, in young mice, early and repetitive exposure to pain and/or sucrose negatively impacted several brain structures and long-term memory.
Through this study, we hope to better understand the mechanisms by which early pain in combination with sucrose treatment affects brain development in preterm infants. We specifically want to understand if inflammation and specific growth factors play key roles. We have established a mouse model that closely mimics the procedures that preterm infants experience in the NICU. We will assess if mice exposed to early pain and/or sucrose have altered levels of inflammatory markers and growth factors in the blood and brain. By assessing the molecular markers that may play a role in impacting the brain development of infants, we hope to develop a better treatment that protects the brain during this critical stage of development. This will ultimately allow these infants to live healthier and more comfortable lives.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schraeder, Emily
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~